Quick Answer
Regen BioPharma Inc reported Total Assets of $274.6 thousand for the year ending 2025.
- Regen BioPharma Inc showed an increase of +70.5% in Total Assets from 2024 to 2025.
- This data is from Regen BioPharma Inc's annual report (Form 10-K), filed with the SEC on December 30, 2025.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2014: $122.8 thousand | Q2 2014: $51.6 thousand | Q4 2014: $64.5 thousand | Q1 2015: $534.8 thousand | Q2 2015: $228.0 thousand | Q4 2015: $318.2 thousand | Q1 2016: $192.9 thousand | Q2 2016: $250.6 thousand | Q3 2016: $319.4 thousand | Q4 2016: $706.7 thousand | Q1 2017: $598.5 thousand | Q2 2017: $965.6 thousand | Q4 2017: $1.15 million | Q1 2018: $757.1 thousand | Q2 2018: $558.8 thousand | Q4 2018: $182.2 thousand | Q1 2019: $43.9 thousand | Q2 2019: $114.3 thousand | Q3 2019: $99.1 thousand | Q4 2019: $41.0 thousand | Q1 2020: $95.5 thousand | Q2 2020: $95.5 thousand | Q4 2020: $150.6 thousand | Q1 2021: $178.0 thousand | Q2 2021: $1.43 million | Q4 2021: $735.2 thousand | Q1 2022: $630.9 thousand | Q2 2022: $689.7 thousand | Q4 2022: $414.1 thousand | Q1 2023: $406.6 thousand | Q2 2023: $285.2 thousand | Q4 2023: $159.5 thousand | Q1 2024: $140.8 thousand | Q2 2024: $170.2 thousand | Q4 2024: $191.4 thousand | Q1 2025: $169.5 thousand | Q2 2025: $196.8 thousand | Q3 2025: $274.6 thousand | Q4 2025: $237.1 thousand.
- Over the full 13 years of available data (2013 to 2025), Regen BioPharma Inc's Total Assets has grown by 136.9%.
- Historical annual values: Fiscal year 2025: $274.6 thousand | Fiscal year 2024: $161.1 thousand | Fiscal year 2023: $353.6 thousand | Fiscal year 2022: $559.0 thousand | Fiscal year 2021: $1.21 million | Fiscal year 2020: $123.2 thousand | Fiscal year 2019: $99.1 thousand | Fiscal year 2018: $209.0 thousand | Fiscal year 2017: $944.2 thousand | Fiscal year 2016: $319.4 thousand | Fiscal year 2015: $220.5 thousand | Fiscal year 2014: $10.7 thousand | Fiscal year 2013: $115.9 thousand.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: